Abstract: A portable stretcher for carrying a subject that includes a support member for supporting a subject's body made of a flexible material; carrying straps connected to opposite sides of the support member at a back side thereof, for allowing manually carrying the stretcher; and at least two sets of handles each set comprising at least one handle, wherein each of the handles connects to the support member. The stretcher is configured for carrying the subject in a sitting posture by having at least two carriers wearing the carrying straps and also in a laying posture, in which the subject horizontally lays over the support member by having the carriers carry the laying subject by using the handles.

Abstract: A transport apparatus includes a frame, a lift mechanism supporting the frame, and a litter deck for supporting a person. The litter deck is adapted to be reconfigured between a chair configuration and a cot configuration. The litter deck is also adapted to be removably mounted to the frame, with the litter deck being adapted to be supported by the frame while the litter deck is in its chair configuration and also while being reconfigured between its chair configuration and its cot configuration.

Abstract: Embodiments herein relate to a wheelchair gearshift arrangement (10), which comprises an axle tube (20) and a pair of wheel attachment adaptors (30) inserted into a respective end (21, 22) of the axle tube (20). The wheel attachment adaptors (30) further includes a respective axle sleeve (40) adapted to receive and hold a respective wheel axle (51) of a respective complete wheelchair wheel (50). Each complete wheelchair wheel (50) having a respective wheel axle centric, axially translatable, gear change mechanism (52). One or more gear change actuators (80) are arranged within the axle tube (20) such that they are operative to selectively, upon user manipulation of an associated gear selector (60), axially translate the associated gear change mechanisms (52) of the respective complete wheelchair wheels (50). Such translation will affect a change of gear ratio between a push-rim (55) and wheel-rim (56) of each respective complete wheelchair wheel (50).

Abstract: A wheelchair suspension comprises a frame, at least one pivot arm, at least one front caster, at least one rear caster, a stabilizing system, and a sensor. The pivot arm is coupled to the frame. The front caster is coupled to the pivot arm. The rear caster is coupled to the frame. The stabilizing system is coupled to the frame and the pivot arm. The sensor is arranged such that tipping of the frame causes actuation of the stabilizing system to at least partially resist further movement of the frame.

Abstract: The invention relates to a recliner device for supporting a lying person, the recliner device having a foot and arranged thereon (i) a first movably mounted thigh support for supporting the first thigh of the person, (ii) a movably mounted second thigh support for supporting the second thigh of the person, the second thigh support being independent of the first thigh support and being combinable with the first thigh support to form a complete support, and (iii) a movably mounted back and head support that is independent of the first and second thigh supports.

Abstract: A system for changing the width of a person support apparatus includes a bed controller for receiving a command signal indicating a command for width alteration, a first motor controlled by the bed controller for driving an extension of a first deck section of the support apparatus thereby altering the width of the first deck section, and a second motor controlled by the bed controller for driving an extension of a second deck section of the support apparatus thereby altering the width of the second deck section. The bed controller controls the first motor and the second motor in a manner that causes the first deck section to reach a first deck section width alteration limit at a first time and the second deck section to reach a second deck section width alteration limit at a second time, wherein the first time and the second time are not equal.

Abstract: A communication system for exchanging data between an actuator system and an external device, e.g. an operation where the communication system in the form of a gateway and a codex interprets the information in the bidirectional data stream and communicates the information on both sides. The communication system is furthermore provided with an RFID circuit integrated in a handset. The RFIC circuit can communicate information about the gateway's unique identification, also known as an MAC-address. This achieves easy connection of an external device to the actuator system without having to enter data manually.

Abstract: A system for use with a hospital bed having circuitry and a standard AC power outlet spaced from the hospital bed is provided. The system includes a cable assembly couplable to the circuitry of the hospital bed. The cable assembly has power conductors and at least one data conductor. The cable assembly also has a plug including a first power coupler coupled to the power conductors and a first data coupler coupled to the at least one data conductor. The system also includes a second data coupler mountable adjacent the standard AC power outlet. The second data coupler is configured to couple to the first data coupler when the first power coupler is coupled to the standard AC power outlet.

Abstract: A wheeled device for mechanical lifting, and in particular a device, system and method for transferring an object, such as a human patient, from one position and location to another position and/or location.

Abstract: A caregiver's helper lift utilizes a unique hoisting apparatus, a lifting harness worn by a patient, and a control apparatus to allow a caregiver to raise and lower a patient into/out-of a wheelchair and into/out-of a vehicle, down to or up off a floor, or to any other position/location that a patient needs to be moved. The lifting harness can clip to a lift attachment which is affixed to a helper lift suspension cable/rope/etc. The caregiver's helper lift utilizes a crane arm to suspend the patient and allow him or her to be repositioned by simply rolling/turning the lift. By actuating the hoisting apparatus control system, the patient can be controllably raised and lowered as desired. The crane arm can be adjustably attached to a power T upright which is itself attached to an H brace base. At least two beam extensions extend laterally from the H brace and provide stability.

Abstract: A patient lift for transporting patients having a hoist assembly, a lift assembly and an integrated flexible load-bearing supporting member. The flexible load-bearing supporting member is retractable into the hoist assembly and has integrated load-bearing, data communications, and power components to transmit data and/or power to/from the hoist assembly and lift assembly.

Abstract: A support platform for body treatment that includes a resilient pad, a cushion movable along a guide passageway in the resilient pad, and a control assembly movable with the cushion to control the position of the cushion to accommodate body parts of a person being treated on the support platform.

Abstract: Disclosed is a rehabilitation training apparatus including a pair of first tracks that are arranged in parallel at an interval, a second track that is perpendicular to the pair of first tracks and is movably connected to the pair of first tracks, a hand holder that is movably provided in the second track and on which a hand of the user is held, a holder driving unit that reciprocally moves the hand holder along the second track, and a track driving unit that reciprocally moves the second track along the pair of first tracks.

Abstract: A plurality of skin-contacting instruments for the manipulation of soft tissue adhesions are disclosed. Each of the instruments comprises a plurality of curvilinear edge surfaces having different radii for contacting the skin in a plurality of locations.

Abstract: The disclosed embodiments provide skin stimulating devices and methods that address the aging effects of skin at a protein level. Particularly, cyclical mechanical strain is used to regulate specific proteins within the skin, so as to produce specific effects. As a non-limiting example, the disclosed embodiments can be used to increase the production of certain proteins (e.g., hyaluronan synthase 3 (HAS3); fibronectin; tropoelastin; procoll1; integrin, etc.) in the skin, which results in anti-aging effects by increasing epidermal cohesion.

Abstract: The disclosed embodiments provide skin stimulating devices and methods that address the aging effects of skin at a protein level. Particularly, cyclical mechanical strain is used to regulate specific proteins within the skin, so as to produce specific effects. As a non-limiting example, the disclosed embodiments can be used to increase the production of certain proteins (e.g., hyaluronan synthase 3 (HAS3); fibronectin; tropoelastin; procoll1; integrin, etc.) in the skin, which results in anti-aging effects by increasing epidermal cohesion.

Abstract: The disclosed embodiments provide skin stimulating devices and methods that address the aging effects of skin at a protein level. Particularly, cyclical mechanical strain is used to regulate specific proteins within the skin, so as to produce specific effects. As a non-limiting example, the disclosed embodiments can be used to increase the production of certain proteins (e.g., hyaluronan synthase 3 (HAS3); fibronectin; tropoelastin; procoll1; integrin, etc.) in the skin, which results in anti-aging effects by increasing epidermal cohesion.

Abstract: An automated chest compression device for performing CPR, with distance sensors disposed on a compressing mechanism and on a structure fixed relative to the CPR patient, for determining inferior/superior movement of the compressing mechanism over the course of multiple compressions.

Abstract: A child proof closure including an outer cap having a set of spaced apart apertures extending through a top surface of the outer cap, an inner cap dimensioned and configured to be assembled within the outer cap having a set of spaced apart receivers corresponding to the at least one set of spaced apart apertures of the outer cap, and a key having a set of spaced apart projections dimensioned and configured to be inserted through the spaced apart apertures of the outer cap to engage the spaced apart receivers of the inner cap when the spaced apart apertures of the outer cap are vertically aligned with the spaced apart receivers of the inner cap for unscrewing the assembled closure from the container by turning the key.

Abstract: A pre-filled syringe storing an anesthetic is disclosed. The pre-filled syringe includes a container configured to store a liquid anesthetic solution. The liquid anesthetic solution includes an anesthetic, water, and a solvent. The container is made of a plastic that is inert to the anesthetic. The pre-filled syringe also includes a plunger made of siliconized bromobutyl rubber that is inert to the anesthetic and a rubber stopper made of siliconized bromobutyl rubber that is inert to the anesthetic. The plunger and the rubber stopper seal the container configured to store the liquid anesthetic solution.

Abstract: The invention is related to a manifold comprising at least two valve receptacles, further comprising a fluid groove arrangement comprising at least two fluid grooves, wherein a first fluid groove of the at least two fluid grooves has a starting point near a first valve receptacle of the at least two valve receptacles and an end point near a second valve receptacle of the at least two valve receptacles and wherein a second fluid groove of the at least two fluid grooves has a starting point near a second valve receptacle of the at least two valve receptacles. The invention is further related to an apparatus comprising a manifold of the aforementioned kind and further comprising an inner body of a dispense interface.

Abstract: A dialysate extraction device comprising a dialysate extraction means including an inlet port and an outlet port adapted to be connected to a flow path of fluid for flowing the fluid therethrough and a projected collection port for collecting the fluid flowing through the inlet and outlet port; a outer circumference wall part mounted on the dialysate extraction means so that it covers a projected end of the collection port and is projected therefrom; a connection member formed with a connection portion to be connected to the collection port and a fitting portion to be fitted into an inner circumference of the outer circumference wall part and adapted to extract the fluid through the collection port under a condition in which the connection portion is connected to the outer circumference wall part; and correction portions formed on the inner circumference of the outer circumference wall part for correcting position and attitude of the connection member relative to the collection port before a tip end of the co

Abstract: A cap for use in enteral feeding from a container. The cap includes a base and an insert cutter. The base has a top surface, a bottom surface, and an outer ring. The top surface has a protruding port suitable for insertion of a spike connector. The protruding port defines a spike insertion chamber extending from a spike connector insert aperture to a spike connector outlet aperture. The outer ring is configured for attachment to a container having a mouth. The insert cutter has a first end portion attached to the bottom surface of the base and about an edge of the spike connector outlet aperture and a second end portion extending over at least a portion of the spike connector outlet aperture. The insert cutter is capable of flexing in an insertion direction of a spike connector inserted through the spike insertion chamber.

Abstract: A rotary die system that includes first and second axially aligned, coacting rotary dies positioned adjacent one another. Each die includes a working surface having a plurality of recesses defined therein. The recesses in the first die are each configured to align with a recess in the second die to form a product cavity upon coaction of the first and second dies. The product cavity is configured to receive a product. Each recess in at least one of the first or second dies includes a pin therein that is configured to puncture a film that at least partially surrounds the product.

Abstract: Systems and methods for controlling delivery of breast milk supplementation are described which include receiving information associated with a breast milk supplement regimen with a breast milk supplement delivery device, the breast milk supplement delivery device including a substrate sized for placement on a surface of a breast region of a lactating female, at least one supplement reservoir associated with the substrate and adapted to contain one or more breast milk supplements, the at least one supplement reservoir including a port with a controllable valve, a data storage component configured to store the breast milk supplement regimen, and a control unit operably coupled to the data storage component and the controllable valve and including a microprocessor and circuitry; and actuating the controllable valve of the at least one supplement reservoir to modulate release of the one or more breast milk supplements based on the received breast milk supplement regimen.

Abstract: A cabinet for securely storing items includes a drawer enclosure, a drawer, a cover, an electric actuator, and a switch. The drawer is slidable at least partially into and out of the enclosure, and includes a compartment. A cover which is configured as a metal belt is designed to selectively block access to the compartments of the drawer when the cover is in a first configuration, and to allow access to the compartment when the cover is in a second configuration. The electric actuator is designed to move the cover from the first configuration to the second configuration in one of two directions. The actuator selects the direction to reduce the time required to make such movement.

Abstract: Provided is a dental composition comprising a first largest group of particles and resin matrix, wherein the first largest group consists of particles whose particle size ranges from 0.7 to 1.5 times the representative particle size of the first largest fraction in a population of particles included in the composition whose particle size ranges from 110 to 1000 ?m; and wherein the ratio of the number of particles included in the first largest group to the number of particles whose particle size ranges from 0.5 to 2.0 times the representative particle size of the first largest fraction is equal to or more than 0.8.

Abstract: A dental composition comprising: a) about 1 to about 80% by weight of particulate material including: (i) calcium silicate, calcium aluminate, tetracalcium aluminoferrite, calcium phosphate, calcium sulfate, silica, alumina, calcium oxide, calcium hydroxide, or mixtures thereof; wherein the particulate material has an average particle size of less than 40 microns; and b) about 1 to about 50% by weight liquid carrier including: (i) water-soluble polymer, and (ii) water.

Abstract: Aerogel, calcined articles, and crystalline articles comprising ZrO2. Exemplary uses of the crystalline metal oxide articles include dental articles (e.g., restoratives, replacements, inlays, onlays, veneers, full and partial crowns, bridges, implants, implant abutments, copings, anterior fillings, posterior fillings, and cavity liner, and bridge frameworks) and orthodontic appliances (e.g., brackets, buccal tubes, cleats, and buttons).

Abstract: A personal hygiene towelette includes a consumable cleaning solution that includes a cleaning agent and a flavoring agent, as well as a textile fabric body, for example a nonwoven textile fabric body, impregnated with the cleaning solution. A personal hygiene assembly including the towelette may further include a sealed housing that houses the personal hygiene towelette.

Abstract: A deodorant stick having a color component as skin-tone pigmentation, for the discreet wearing of deodorant. The color component matches a color of user's human skin, acting as camouflage that changes its color as it is applied on the skin to match the skin. The deodorant stick includes a plastic casing, containing an interior plastic casing where the interior casing contains a skin-color pigmented deodorant, a fitted plastic cover, a plastic wheel mechanism, and a set of rubber-based grips. The fitted plastic cover may be transparent or of a color that matches the color component included in the deodorant stick. The rubber-based grips matches the color of the color component included in the deodorant stick.

Abstract: Provided is a cosmetic in the form of an oil-in-water emulsion unckuding (A) a salt of higher fatty acid component containing a liquid higher fatty acid and (B) an oil-soluble ultraviolet absorber, being substantially free of a hydrophilic surfactant other than the (A) component and having a pH of 7.1 to 9.5 and a method for production thereof. The cosmetic having ultraviolet protection efficacy is excellent in fresh feel, water resistance and rinsability using water with soap when applied to the skin and storage stability. The cosmetic is suitable for sunscreen cosmetics and is also useful for makeup cosmetics such as foundation and makeup base, skin care cosmetics such as milky lotion, cream and serum and hair cosmetics.

Abstract: A personal care composition for application to the skin or hair comprising a cosmetically acceptable carrier and zinc X halide precursors wherein the precursors are a zinc ion source, an X source, and a halide source, wherein the halide source can be part of the zinc ion source, the X source, or a halogen acid, wherein the precursors can complex into the zinc X halide when the composition is applied to the skin or hair, wherein X is an amino acid or trimethylglycine. Methods of making and using the compositions are also provided. When the precursors complex into a zinc X halide, the complex can be used to deliver zinc salts to block perspiration and provide antibacterial effects.

Abstract: A method of solubilizing a composition, such as an organic manufactured photochromic dye that is free of carcinogens, non-mutagenic, non-toxic to human skin in any concentration, and suitable for application to, and absorbable by, human skin. The photochromic dye is suitable to be applied directly to human skin, and which dye is configured to indicate exposure to UV rays. The composition is configured to change color upon exposure to UVA, UVB and/or UVC rays. The composition can be used with other compositions, such as sunscreen, and be applied to human skin prior to application of the sunscreen, or, formulated with the sunscreen such that when the active ingredients of the sunscreen diminish, the photochromic dye will change color to generate a visual indicator of this condition.

Abstract: The present invention relates to a fluid composition, characterized in that it comprises, in a cosmetically acceptable aqueous support: (a) at least one fatty phase; (b) a photoprotective system capable of screening out UV radiation; (c) at least one superabsorbent polymer; (d) at least one crosslinked copolymer of methacrylic acid and of a C1-C4 alkyl acrylate. Another subject of the present invention lies in the use of the combination of a superabsorbent polymer and of a crosslinked copolymer of methacrylic acid and of an alkyl acrylate in a fluid composition comprising, in a cosmetically acceptable aqueous support, at least one photoprotective system capable of screening out UV radiation, as a freshness agent and/or as a stabilizer for the composition.

Abstract: A method for dyeing keratinous fibers, in particular, human hair, in which, after a thickened pre-treatment agent (M1) containing no oxidation dye precursors has been applied and allowed to react, a coloring agent (M2) is applied and allowed to react immediately thereafter and without rinsing. By carrying out said method, hair can be colored in a dyeing step and simultaneously multi-tonal dyeing with highlights or lowlights can be achieved.

Abstract: The invention relates to substances which are capable of protecting FGF-2, to a composition for preventing or controlling degradation of FGF-2, and a method of protecting FGF-2 in the skin from degradation. In particular, the invention relates to an extract of Hibiscus Abelmoschus or ambrette, a rebokza extract, a gougizi berry extract, a banha extract, a lessonia extract, a mustard flour extract, a wooyin extract, a barley extract, and/or a sesame extract, in amounts effective to protect FGF-2 from its degradation. Further, the present invention allows the extracellular matrix to be restructured, particularly at the dermis, which is useful, for example, for controlling aging.

Abstract: According to the present invention the extract of plant origin of the Globularia genus is used for a non-therapeutic cosmetic treatment of the skin and/or appendages. Preferably the species is Globularia cordifolia and the extract is obtained by in vitro plant culture. The extract can be used in particular for preventing and/or treating skin ageing by stimulating the 10 reactions of detoxification and cellular regeneration through a hormetic type response, for improving the transparency and radiance of complexion, for preventing or treating sensitive and reactive skins, for preventing or treating rednesses, for preventing protein glycation, for increasing and/or maintaining the number of dermal stem cells, for increasing and/or maintaining the dermal macromolecules, in particular collagen and elastin, for increasing the volume of the dermis, for 15 preventing and/or treating fines lines and wrinkles, for firming skin, for preventing hair loss and/or stimulating hair regrowth.

Abstract: A composition for applying to skin in need of treatment for skin barrier restoration, hydration and moisturization, the composition comprising extracts of Ampelopsis grossedentata and Albizia julibrissin. Also provided are methods for treating skin in need of skin barrier treatment, methods of treating skin to reduce the signs of aging and methods of treating skin to reduce the signs of inflammation with a composition comprising extracts of Ampelopsis grossedentata and Albizia julibrissin.

Abstract: A skin defense system and a skin rejuvenation and defense system. The skin rejuvenation and defense system includes a skin rejuvenation application and a skin defense application that work together synergistically to rejuvenate and defend the skin from environmental insults that can accelerate the aging process and deprive the skin of its vitality. The skin rejuvenation application invigorates, oxygenates, and detoxifies the skin. After the skin has been opened up and made receptive by the skin rejuvenation application, the skin defense application absorbs into the skin to deeply moisturize and revitalize the skin. In addition to moisturizers, emollients, and similar ingredients that improve health and appearance of the skin, the skin defense application includes ingredients that can reverse and protect the skin from damage caused by pollutants (e.g., pollutants up to 2.5 micrometers) and pre- and pro-biotics that promote the growth and development of beneficial skin flora.

Abstract: The present invention relates to a solid pharmaceutical dosage forms and methods for preparing the solid pharmaceutical dosage form that contains fingolimod or its pharmaceutically acceptable salts, conjugates or complexes thereof. The solid pharmaceutical dosage forms may rapidly disintegrates in a patient's oral cavity.

Abstract: The present invention relates to glucocorticoid-containing pharmaceutical compositions or kits for use in acute emergency situations where acute glucocorticoid therapy is required. Notably, the invention relates to pharmaceutical compositions and kits that are designed to be administered by non-medically trained persons outside a hospital or another medical or clinical setting. The invention also relates to a method for treating a disorder requiring acute glucocorticoid therapy by providing a fast onset of action of a glucocorticoid.

Abstract: Described herein is a cell tissue gel containing collagen and hyaluronan at a weight ratio of 0.01-100:1.

Abstract: In one aspect, a dry formulation for the effective administration of multiple medications simultaneously for one or more ailments may be provided. The dry formulations include one or more of the following actives in combination with pharmaceutically acceptable excipients or additives: a) at least one antibiotic; b) at least one anti-inflammatory steroid; and c) at least one antifungal agent.

Abstract: The invention compositions comprising a continuous hydrophobic phase and liposomes as a vehicle for delivery of an antigen capable of inducing a cytotoxic T lymphocyte (CTL) response and methods for their use in the treatment of cancer.

Abstract: There are provided compositions comprising lipidated glycosaminoglycan particles, methods for their preparation and uses thereof for the efficient in-vivo and in-vitro delivery of nucleic acids, such as, siRNA molecules.

Abstract: Disclosed herein are heat-stable dry powders which include peptides or protein such as oxytocin for use as a pharmaceutical composition. The composition is highly stable at increased temperatures and relatively high humid environments, and are intended for storage at room temperature with an improved shelf-life. In particular, the dry powders are intended for inhalation, however, other routes of administration can be used when reconstituted in solution.

Abstract: An oral delivery product comprising a semi-permeable pouch designed for delivery of an active agent in the oral cavity of a subject. The pouch encloses multiple particles, and the particles are alginate matrices that comprise an active agent, e.g. nicotine. The alginate is e.g. sodium alginate, such as PROTANAL® LFR 5/60 or PROTANAL® LF 10/60.

Abstract: A thermoformed pharmaceutical dosage form having a breaking strength of at least 300 N, said dosage form comprising a pharmacologically active ingredient (A), a free physiologically acceptable acid (B) in an amount of from 0.001 wt.-% to 5.0 wt.-%, based on the total weight of the pharmaceutical dosage form, and a polyalkylene oxide (C) having a weight average molecular weight Mw of at least 200,000 g/mol.

Abstract: A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or semi-solid mixture of waxy materials. Oral dosage forms can be prepared by melt-blending the components described herein and filling gelatin capsules with the formulation.